IPHA vs AMZN: Which Stock is Better?
Side-by-side comparison of Innate Pharma Sa and Amazon Com Inc in 2026
IPHA
Innate Pharma Sa
$1.41
AMZN
Amazon Com Inc
$248.50
Key Metrics Comparison
| Metric | IPHA | AMZN | Winner |
|---|---|---|---|
| Market Cap | $132.24M | $2.68T | AMZN |
| P/E Ratio | N/A | 34.73 | AMZN |
| EPS (TTM) | $N/A | $7.17 | AMZN |
| Revenue Growth | -0.5% | 0.1% | AMZN |
| Gross Margin | -384.4% | 50.3% | AMZN |
Analyze IPHA
Full quant analysis
Analyze AMZN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IPHA or AMZN a better investment?
Comparing IPHA and AMZN: Innate Pharma Sa has a market cap of $132.24M while Amazon Com Inc has $2.68T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IPHA and AMZN?
IPHA (Innate Pharma Sa) and AMZN (Amazon Com Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IPHA or AMZN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IPHA or AMZN?
AMZN has higher revenue growth at 0.1% vs -0.5% for IPHA.
Which company is more profitable: IPHA or AMZN?
Amazon Com Inc (AMZN) has higher gross margins at 50.3% compared to -384.4% for IPHA.
Which is the larger company: IPHA or AMZN?
Amazon Com Inc (AMZN) is larger with a market cap of $2.68T compared to $132.24M for IPHA.
Should I buy IPHA or AMZN in 2026?
Both IPHA and AMZN have investment merit. IPHA trades at $1.41 while AMZN trades at $248.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IPHA and AMZN stock?
Key differences: Market Cap ($132.24M vs $2.68T), P/E Ratio (N/A vs 34.7x), Revenue Growth (-0.5% vs 0.1%), Gross Margin (-384.4% vs 50.3%).